Viatris (VTRS)
(Delayed Data from NSDQ)
$11.57 USD
+0.10 (0.87%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $11.57 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth D Momentum C VGM
- YR Estimate
- 12/31/2023
- 12/31/2022
- 12/31/2021
- 12/31/2020
- 12/31/2019
- Revenue - Line of Business (LOBR)
- Total Net Sales
- 15,388.40
- 16,218.10
- 17,813.60
- 11,819.90
- 11,370.30
- Revenue - Line of Business (LOBR)
- Net Sales: Developed Markets
- 9,251.90
- 9,768.90
- 10,428.70
- 8,510.90
- 8,240.00
- Revenue - Line of Business (LOBR)
- Net Sales: Emerging Markets
- 2,551.60
- 2,615.60
- 3,144.70
- 1,853.80
- 1,723.20
- Revenue - Line of Business (LOBR)
- Net Sales: JANZ
- 1,424.50
- 1,632.40
- 2,027.40
- 1,195.30
- 1,192.50
- Revenue - Line of Business (LOBR)
- Net Sales: Greater China
- 2,160.40
- 2,201.20
- 2,212.80
- 259.90
- 214.60
- Revenue - Line of Business (LOBR)
- Other revenues
- 38.50
- 44.60
- 72.70
- 126.10
- 130.20
- Revenue - Line of Business (LOBR)
- Net Sales: Developed Markets: Brands
- 5,239.00
- 5,160.40
- 5,759.20
- 3,920.70
- --
- Revenue - Line of Business (LOBR)
- Net Sales: Developed Markets: Complex Gx
- --
- 1,218.00
- 1,241.60
- 1,202.60
- --
- Revenue - Line of Business (LOBR)
- Net Sales: Developed Markets: Generics
- 4,012.90
- 3,390.50
- 3,427.90
- 3,387.60
- --
- Revenue - Line of Business (LOBR)
- Net Sales: JANZ: Brands
- 782.90
- 922.60
- 1,197.10
- 617.00
- --
- Revenue - Line of Business (LOBR)
- Net Sales: Emerging Markets: Generics
- 925.10
- 949.00
- 1,413.70
- 1,361.10
- --
- Revenue - Line of Business (LOBR)
- Net Sales: JANZ: Generics
- 641.60
- 665.70
- 783.80
- 535.50
- --
- Revenue - Line of Business (LOBR)
- Net Sales: JANZ: Complex Gx
- --
- 44.10
- 46.50
- 42.80
- --
- Revenue - Line of Business (LOBR)
- Net Sales: Emerging Markets: Brands
- 1,626.50
- 1,615.90
- 1,677.20
- 443.30
- --